Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Gold and Oil: Remembering the '70s

Before I get started on my weekly commentary, I want to thank you all for the waterfall of responses to A Boomer's Plea posted last weekend, in what I must confess was my most impassioned missive of a multi-decade writing career. Speaking out as a member of the generat...
Streetwise Reports | April 28, 2020 |

Amgen Shares React Favorably to Enbrel Patent Case Victory

Amgen shares are trading 5–6% higher today on news that the company has won its Enbrel (etanercept) patent court case. On Friday, August 9, 2019, Amgen Inc. (AMGN:NASDAQ) announced that it had won its Enbrel patent case. The company advised that the U.S. District C...
Streetwise Reports | August 14, 2019 |

Kodiak Shares Soar on $225 Million Royalty Deal for Retinal Drug

Shares of Kodiak Sciences traded more than 100% higher at times after the company reported that it entered into a $225 million royalty agreement for the firm's KSI-301 used in the treatment of retinal vascular diseases including age-related macular degeneration and diabetic ey...
Streetwise Reports | December 3, 2019 |

Intra-Cellular Therapies Shares Rise 200% on FDA Approval of Adult Schizophrenia Drug

Shares of Intra-Cellular Therapies opened greater than 100% higher today after the company reported that the FDA approved its antipsychotic CAPLYTA® (lumateperone) drug for the treatment of schizophrenia in adults. This morning a biopharmaceutical company foc...
Streetwise Reports | December 27, 2019 |

First Helium creates two premium helium projects in Alberta

The Alberta-focused, cash-flowing, multi-project helium developer First Helium stock (TSXV:HELI) is seeing a demand for its assets. The company has two premier helium projects in Alberta that are high-value, low risk to high-impact exploration opportunities. The company...
Brieanna McCutcheon | July 5, 2023 |

Mexican gold junior I really like

Editor’s note: The Pediment Gold story was first reported by Ticker Trax’s Thom Calandra in an article posted her e . I first wrote about Pediment Gold Corp ( TSX: T.PEZ , Stock Forum ) in a private report delivered on June 18, 2007....
Michael S. (Mickey) Fulp | October 28, 2012 |

Explorer a 'Highly Attractive Speculative Play'

This miner has taken a hit, but technical analyst Clive Maund explains why the stock may be a good buy at current levels. We got enthusiastic about Nexus Gold Corp. (NXS:TXS.V; NXXGF:OTCQB) earlier in the year, but we were too early and it proceeded to drop back nea...
Streetwise Reports | October 16, 2019 |

Meet the Fresh, New Face of the Booming Plant-based Economy

(Click image to play video) Stockhouse investors and readers know the plant-based economy is booming. And they also know that while opportunities abound, not all of these companies are created equal. But one, uniquely-positioned West Vancouver, BC-based company ...
Dave Jackson | January 29, 2021 |

Hemostemix Founder: A Man with a Compassionate Heart

The Canadian stem cell company Hemostemix Inc. ( TSX-V: HEM , OTC: HMTXF ) was founded by a man who truly had a compassionate heart and a clear intent to establish a breakthrough in heart disease using the same technology that saved his life. Roger Bergersen, who train...
Featured Submission | December 14, 2020 |

And Here Comes Whirlaway!: What Silver and the Horse Have in Common

Sector expert Michael Ballanger anticipates the come-from-behind winning run of silver. In the late 1930s, a young stallion was born in Lexington, Ky., at the legendary Calumet Farm, that went on to win seventeen major races from 1940–1942, including the Triple Crown (Kent...
Streetwise Reports | May 19, 2020 |
1 2